(Q79401559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Less is more risky? Growth hormone and insulin-like growth factor 1 levels and cardiovascular risk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Patrick Maison

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Philippe Chanson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Endocrinology and Metabolism

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

650-651

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Clinical review: Growth hormone and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0350

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17143307%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference